Award recordCONTRACT

BIOLOGICS, INC.

PIID VA25114P2168· VHA· 583-INDIANAPOLIS· 6505 · DRUGS AND BIOLOGICALS· FY2014· $28,507 net obligations· UEI GVRYEDLFU6J3· NC

Description

ZYKADIA 150MG CAPSULES

First action · last action
2014-06-24 · 2015-07-18
Transactions
3
First transaction's obligation
$57,015
Base + all options value (sum of deltas)
$28,507
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325414 · BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$57,015$0Base award · 2014-06-24 · this action $57,015 · running total $57,015Modification P00001 · 2014-07-30 · this action -$14,254 · running total $42,761Modification P00002 · 2015-07-18 · this action -$14,254 · running total $28,507
  • Base2014-06-24+$57,015= $57,015
  • Mod P000012014-07-30-$14,254= $42,761
  • Mod P000022015-07-18-$14,254= $28,507
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2014-06-24+$57,015$57,015ZYKADIA 150MG CAPSULES
Mod P00001· OTHER ADMINISTRATIVE ACTION2014-07-30−$14,254$42,761ZYKADIA 150MG CAPSULES
Mod P00002· OTHER ADMINISTRATIVE ACTION2015-07-18−$14,254$28,507ZYKADIA 150MG CAPSULES

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI GVRYEDLFU6J3)

AwardOffice · PSC / listingNet obligationsFY
36C26126P0068261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$29,628FY2026
36C26125P1616261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$18,697FY2025
36C26125P1544261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$77,456FY2025
36C25925P1069NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$10,035FY2025
36C26223P0842262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$0FY2023
36C24222P0293242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$10,296FY2022

Other recipients under 6505 from 583-INDIANAPOLIS (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25116F0847ACTELION PHARMACEUTICALS US, INC.583-INDIANAPOLIS$4,614FY2016
VA25116F0730CSL BEHRING L.L.C.583-INDIANAPOLIS$26,724FY2016
VA25116F0509CSL BEHRING L.L.C.583-INDIANAPOLIS$26,724FY2016
VA25116F0406ROCHE DIAGNOSTICS CORPORATION583-INDIANAPOLIS$17,601FY2016
VA25116P0414ASD SPECIALTY HEALTHCARE, LLC583-INDIANAPOLIS$35,317FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25114P2168_3600_-NONE-_-NONE- · retrieved 2026-09-27.